A review of prospective Clinical Trials for neurogenic bladder: Pharmaceuticals

Journal Title: Central European Journal of Urology - Year 2014, Vol 67, Issue 3

Abstract

Introduction The neurogenic urinary bladder is defined as a dysfunctional bladder associated with a known neurological injury. We review the data from good quality clinical trials looking at drug therapy for the neurogenic bladder. Materials and methods In order to identify as many prospective trials as possible, we performed Internet searches, using the same search string: Urinary Bladder, neurogenic (MESH). In each case, the search was limited to clinical trial, prospective trial, subjects were human and the language was English. There was no year limit for our search. The next step was duplicate removal, which led to a final number of 580 papers. We defined clear inclusion criteria for the papers. Results A total of 82 full text papers were reviewed and analyzed according to the previously mentioned algorithm. The oldest two prospective clinical trials date back to 1976, with an obvious increase in number of trials each year, reaching more than five trials per year after 2001, which demonstrates increased interest toward the subject. The total number of patients included in the trials is 3904, 888 of which are children. The male: female ratio is close to 1, although there were 9 studies where no information regarding the sex of the patients was available. Conclusions Our analysis stresses the acute need for good quality trials looking at the drugs used for the management of the patients with neurogenic bladders, with adequate statistical power to support the data they present

Authors and Affiliations

Cristian Persu, Emmanuel Braschi, John Lavelle

Keywords

Related Articles

Secondary infertility and the aging male, overview

Introduction Old men preparing themselves for marriage late in their lives might face infertility. Infertility in this group of men should be considered from a wider perspective, as they face any age–related health troub...

Association between pre–biopsy white blood cell count and prostate biopsy – related sepsis

Introduction Despite all preventive measures and improved biopsy techniques, serious, life–threatening complications of prostate biopsy, including sepsis, still exist. In the present study, in order to identify the risk...

Knowledge about virus biology is crucial for us

Editorial; nie zawiera komentarza

Significance of ASAP and extensive HG-PIN in clinical practice

Introduction Prostate cancer (PCa) is one of the most commonly diagnosed neoplasms in elderly men. The precancerous lesion of PCa is considered a high-grade prostate intraepithelial neoplasm (HG-PIN), while atypical smal...

Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessedby a pathologist?

Introduction In some patients submitted to transurethral resection of the prostatic (TURP) or prostatectomy (OAE) due to benign prostate hyperplasia (BPH), pathological evaluations (PE) revealed coexistence of prostate c...

Download PDF file
  • EP ID EP356358
  • DOI 10.5173/ceju.2014.03.art11
  • Views 40
  • Downloads 0

How To Cite

Cristian Persu, Emmanuel Braschi, John Lavelle (2014). A review of prospective Clinical Trials for neurogenic bladder: Pharmaceuticals. Central European Journal of Urology, 67(3), 264-269. https://europub.co.uk/articles/-A-356358